Akoya Biosciences, Inc. (AKYA)
USD 1.03
(-11.97%)
USD 1.03
(-11.97%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 75.25 Million USD | 4.29% |
| 2022 | 72.15 Million USD | 122.21% |
| 2021 | 32.47 Million USD | -3.83% |
| 2020 | 33.76 Million USD | 36.86% |
| 2019 | 24.67 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 75.46 Million USD | 0.29% |
| 2024 Q2 | 75.68 Million USD | 0.28% |
| 2023 Q1 | 71.69 Million USD | -0.64% |
| 2023 FY | 75.25 Million USD | 4.29% |
| 2023 Q3 | 71.48 Million USD | -0.65% |
| 2023 Q2 | 71.95 Million USD | 0.37% |
| 2023 Q4 | 75.25 Million USD | 5.27% |
| 2022 Q2 | 52.35 Million USD | 29.17% |
| 2022 Q1 | 40.53 Million USD | 24.82% |
| 2022 Q4 | 72.15 Million USD | 16.14% |
| 2022 FY | 72.15 Million USD | 122.21% |
| 2022 Q3 | 62.12 Million USD | 18.68% |
| 2021 Q4 | 32.47 Million USD | -0.47% |
| 2021 Q2 | 32.58 Million USD | -3.56% |
| 2021 Q1 | 33.78 Million USD | 0.07% |
| 2021 FY | 32.47 Million USD | -3.83% |
| 2021 Q3 | 32.62 Million USD | 0.13% |
| 2020 Q4 | 33.76 Million USD | 0.0% |
| 2020 FY | 33.76 Million USD | 36.86% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 24.67 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AngioDynamics, Inc. | 3.93 Million USD | -1810.485% |
| AtriCure, Inc. | 60.59 Million USD | -24.196% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | -24.518% |
| BioLife Solutions, Inc. | 18.31 Million USD | -310.977% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 97.018% |
| Daxor Corporation | 755.65 Thousand USD | -9858.725% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | -1457.409% |
| Femasys Inc. | 4.25 Million USD | -1667.281% |
| GlucoTrack, Inc. | 196 Thousand USD | -38294.898% |
| Harvard Bioscience, Inc. | 30.7 Million USD | -145.095% |
| Hologic, Inc. | 2.49 Billion USD | 96.986% |
| ICU Medical, Inc. | 1.57 Billion USD | 95.23% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 191.661% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -1960.104% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | -352.683% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 91.367% |
| Microbot Medical Inc. | 40 Thousand USD | -188035.0% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -1638706.62% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 90.856% |
| Nephros, Inc. | 1.39 Million USD | -5313.957% |
| NovoCure Limited | 596.24 Million USD | 87.379% |
| NEXGEL, Inc. | 513 Thousand USD | -14569.396% |
| NEXGEL, Inc. | 513 Thousand USD | -14569.396% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | -11.448% |
| OraSure Technologies, Inc. | 11.38 Million USD | -560.818% |
| Pro-Dex, Inc. | 7.53 Million USD | -898.593% |
| Pulse Biosciences, Inc. | 8.08 Million USD | -830.67% |
| Predictive Oncology Inc. | 2.18 Million USD | -3337.858% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -3783.135% |
| QuidelOrtho Corporation | 2.27 Billion USD | 96.691% |
| Repligen Corporation | 510.14 Million USD | 85.248% |
| Sanara MedTech Inc. | 9.11 Million USD | -725.776% |
| STAAR Surgical Company | 31.46 Million USD | -139.152% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -25409.831% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 95.81% |
| Jin Medical International Ltd. | - USD | -Infinity% |